Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle Interventions to Lose Weight and Reduce EDC Exposure in Individuals With Overweight/Obesity

The goal of this study is to examine the relationship in individuals with overweight/obesity and endocrine disrupting chemical (EDC) exposure through a two-armed, randomized clinical trial. The main questions this study aims to answer are: 1. If MM's 12-week EDC intervention program (EDC testing and report-back, EDC reduction curriculum) can reduce weight? 2. If a 12-week validated digital weight loss program can reduce EDC exposures? 3. What is the effectiveness of the two interventions at reducing weight and urinary EDC metabolites? Participants will be assigned to one of these two arms. Participants will collect their urine and blood samples pre- and post-intervention, and will take a comprehensive exposure survey before sending back their samples. This exposure survey will ask about participant's weight loss literacy, environmental health literacy, product use, diet, and lifestyle behaviors.

Inclusion Criteria: * BMI over 25 * Not pregnant or breast feeding * Do not have diabetes, kidney disease, liver disease, cardiac disease, pulmonary disease or cancer. * Do not smoke * Not in another weight loss program or on GLP-1 * Have access to a smartphone or computer Exclusion Criteria: * BMI under 25 * Pregnant or breast feeding * Have diabetes, kidney disease, liver disease, cardiac disease, pulmonary disease or cancer. * Smoke * In another weight loss program or on GLP-1 * Do not have access to a smartphone or computer